Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,477.16
(
-1.74%
)
US TECH 100
23,040.00
(
-2.01%
)
Dow Jones
45,960.11
(
-1.01%
)
Brent Oil
101.12
(
0.45%
)
Bitcoin
68,941.00
(
0.23%
)
News Focus
News Focus
Post# of 257295
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122815
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: rkrw post# 2758

Thursday, 07/08/2004 2:18:18 PM

Thursday, July 08, 2004 2:18:18 PM

Post# of 257295
>> Could this be a good reason why qlti may better compete against macugen than expected? And perhaps visudyne is the real competition for squalamine? <<

Some will agree with that, but not me. I believe that Visudyne is on its last legs and will be gone within five years.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today